Routine annual meeting results with no surprise. The increased share reserves signal ongoing equity compensation needs but do not represent immediate dilution. Monitor future 10-Q for actual share issuance under these plans.
Price Chart
Executive Summary
Assembly Biosciences held its 2026 annual meeting on June 4, 2026, where stockholders approved an increase in shares reserved under the 2018 Stock Incentive Plan from 1,478,333 to 2,678,333 (a 1,200,000-share increase) and an increase in the Employee Stock Purchase Plan from 225,000 to 515,000 shares. All nine director nominees were elected, and the appointment of Ernst & Young as auditor was ratified. This is a routine governance filing with no material financial impact.
Key Facts
- Stockholders approved Amendment No. 3 to the 2018 Stock Incentive Plan, increasing authorized shares from 1,478,333 to 2,678,333.
- Stockholders approved Amendment No. 2 to the ESPP, increasing reserved shares from 225,000 to 515,000.
- All nine director nominees were elected with overwhelming support (over 99% of votes cast for each).
- Ernst & Young LLP was ratified as independent auditor for fiscal 2026.
- Say-on-pay proposal passed with approximately 99.8% of votes cast in favor.
Financial Impact
No financial figures reported. The share reserve increases enable future equity compensation but no shares were issued in this filing.
Risk Factors
- Potential future dilution from the 1,200,000 additional shares authorized under the stock incentive plan.
- No operational or financial updates provided in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-259481 |
| Document: asmb-ex10_2.htm | 0001193125-26-259481 |
| Document: asmb-ex10_1.htm | 0001193125-26-259481 |
| Document: 0001193125-26-259481-index-headers.html | 0001193125-26-259481 |
| Document: 0001193125-26-259481-index.html | 0001193125-26-259481 |
| Document: 0001193125-26-259481.txt | 0001193125-26-259481 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 15, 2026 10w ago | Institutional Cluster | $30.01 $35.28 | ▲ +17.56% | ▲ +18.75% | $20.30 (−32.36%) |
Aug 13, 2026 10w ago | Press Release | $32.95 $34.38 | ▲ +4.34% | ▲ +5.71% | $20.30 (−38.39%) |
Jun 11, 2026 19w ago | Institutional Cluster | $22.53 $24.15 | ▲ +7.19% | ▲ +6.76% | $20.30 (−9.90%) |
Jun 5, 2026 20w ago | 8-K | $22.56 $23.34 | ▲ +3.48% | ▲ +1.37% | $20.30 (−10.00%) |
May 22, 2026 22w ago | 424B5 | $28.75 $26.92 | ▲ +6.37% | ▲ +7.45% | $20.30 (+29.39%) |
May 22, 2026 22w ago | 8-K | $28.34 $26.92 | ▼ −5.01% | ▼ −6.67% | $20.30 (−28.37%) |
May 22, 2026 22w ago | Press Release | $28.34 $26.92 | ▼ −5.01% | ▼ −6.67% | $20.30 (−28.37%) |
May 7, 2026 24w ago | Press Release | $29.74 $30.30 | ▲ +1.88% | ▲ +0.42% | $20.30 (−31.74%) |
Mar 30, 2026 30w ago | EFFECT | $26.64 $28.53 | ▲ +7.09% | ▲ +2.79% | $20.30 (−23.80%) |
Mar 19, 2026 31w ago | Press Release | $28.46 $27.70 | ▼ −2.67% | ▼ −0.52% | $20.30 (−28.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers